Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications (original articles or review articles) published in 2024 from OUS - Department of Pharmacology

23 publications found

Abdullah R, Bjørnebekk A, Hauger LE, Hullstein IR, Edvardsen T, Haugaa KH, Almaas VM (2024)
Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids
Eur J Prev Cardiol, 31 (5), 599-608
DOI 10.1093/eurjpc/zwad362, PubMed 37992194

Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, Larstorp ACK, Søraas CL, Rossebø AB, Rösner A, Grytaas MA, Gerdts E (2024)
Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
High Blood Press Cardiovasc Prev, 31 (2), 157-166
DOI 10.1007/s40292-024-00632-6, PubMed 38530572

Bashour H, Smorodina E, Pariset M, Zhong J, Akbar R, Chernigovskaya M, Lê Quý K, Snapkow I, Rawat P, Krawczyk K, Sandve GK, Gutierrez-Marcos J, Gutierrez DN, Andersen JT, Greiff V (2024)
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Commun Biol, 7 (1), 922
DOI 10.1038/s42003-024-06561-3, PubMed 39085379

Bergan S, Vethe NT (2024)
The potential for therapeutic drug monitoring of belatacept and other biologicals in solid organ transplantation
Br J Clin Pharmacol (in press)
DOI 10.1111/bcp.16170, PubMed 39056476

Bialer M, Johannessen SI, Koepp MJ, Perucca E, Perucca P, Tomson T, White HS (2024)
Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). I. Drugs in preclinical and early clinical development
Epilepsia (in press)
DOI 10.1111/epi.18056, PubMed 39008349

Bialer M, Johannessen SI, Koepp MJ, Perucca E, Perucca P, Tomson T, White HS (2024)
Progress report on new medications for seizures and epilepsy: A summary of the 17th Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII). II. Drugs in more advanced clinical development
Epilepsia (in press)
DOI 10.1111/epi.18075, PubMed 39171993

Brobak KM, Halvorsen LV, Aass HCD, Søraas CL, Aune A, Olsen E, Bergland OU, Rognstad S, Blom KB, Birkeland JAK, Høieggen A, Larstorp ACK, Solbu MD (2024)
Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage
Blood Press, 33 (1), 2323980
DOI 10.1080/08037051.2024.2323980, PubMed 38606688

Dalaker VM, Furuhaugen H, Brekke M, Bjørnaas MA, Krpo M, Øiestad EL, Vallersnes OM (2024)
Drugs in blood and urine samples from victims of suspected exposure to drink spiking: A prospective observational study from Oslo, Norway
PLoS One, 19 (7), e0306191
DOI 10.1371/journal.pone.0306191, PubMed 38985694

Ghannoum M, Waters PJ, Hovda KE, Choquette G, Elgstøen KBP, Nygaard I, Rootwelt H, Hickey D, Yazdani M, Bourque DK (2024)
Can endogenous ethylene glycol production occur in humans? A detailed investigation of adult monozygotic twin sisters
Clin Toxicol (Phila), 1-9 (in press)
DOI 10.1080/15563650.2024.2401076, PubMed 39327950

Gjerulfsen CE, Nikanorova M, Olofsson K, Johannessen Landmark C, Rubboli G, Møller RS (2024)
Fenfluramine treatment in pediatric patients with Dravet syndrome reduces seizure burden and overall healthcare costs: A retrospective and observational real-world study
Epilepsia Open, 9 (5), 1891-1900
DOI 10.1002/epi4.13029, PubMed 39140199

Halvorsen LV, Søraas CL, Larstorp ACK, Hjørnholm U, Kjær VN, Liestøl K, Aune A, Olsen E, Brobak KM, Bergland OU, Rognstad S, Aarskog NR, Heimark S, Fadl Elmula FEM, Gerdts E, Mo R, Solbu MD, Opdal MS, Kjeldsen SE, Rostrup M, Høieggen A (2024)
Effect of Therapeutic Drug Monitoring on Adherence and Blood Pressure: A Multicenter Randomized Clinical Trial
Am J Hypertens, 37 (10), 826-836
DOI 10.1093/ajh/hpae059, PubMed 38713475

Havig SM, Berg-Pedersen RM, Krabseth HM, Müller LD, Haugaa K, Zare HK, Gjesdal K, Krajci P, Opdal MS (2024)
Effect on QTc interval by switching from methadone to equipotent R-methadone dose in methadone maintenance treatment patients
Basic Clin Pharmacol Toxicol, 134 (4), 519-530
DOI 10.1111/bcpt.13982, PubMed 38308508

Heger K, Burns ML, Nikanorova M, Johannessen SI, Johannessen Landmark C (2024)
Pharmacokinetic Variability of Rufinamide and Stiripentol in Children With Refractory Epilepsy: A Retrospective Study of Therapeutic Drug Monitoring From the National Epilepsy Centers in Denmark and Norway
Ther Drug Monit, 46 (5), 664-671
DOI 10.1097/FTD.0000000000001219, PubMed 38758628

Helset E, Cheng V, Sporsem H, Thorstensen C, Nordøy I, Gammelsrud KW, Hanssen G, Ponzi E, Lipman J, von der Lippe E (2024)
Meropenem pharmacokinetic/pharmacodynamic target attainment and clinical response in ICU patients: A prospective observational study
Acta Anaesthesiol Scand, 68 (4), 502-511
DOI 10.1111/aas.14376, PubMed 38286568

Kirkeby K, Cockerell I, Christensen J, Hoei-Hansen CE, Holst L, Fredriksen MG, Lund C, Johannessen Landmark C (2024)
Pharmacokinetic variability of everolimus and impact of concomitant antiseizure medications in patients with tuberous sclerosis complex: A retrospective study of therapeutic drug monitoring data in Denmark and Norway
Medicine (Baltimore), 103 (32), e39244
DOI 10.1097/MD.0000000000039244, PubMed 39121325

Larsen RE, Hole K, Selle ML, Johannessen Landmark C, Krogstad T, Holm LB (2024)
Access to a tailored mobile application enhances medication adherence among young users of antidepressants
Front Pharmacol, 15, 1379700
DOI 10.3389/fphar.2024.1379700, PubMed 38659579

Lauritzen T, Munkhaugen J, Bergan S, Peersen K, Svarstad AC, Andersen AM, Pahnke J, Husebye E, Vethe NT (2024)
The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study
Atheroscler Plus, 55, 31-38
DOI 10.1016/j.athplu.2024.01.001, PubMed 38293288

Levernaes MCS, Solheim SA, Broderstad L, Zandy E, Mørkeberg J, Dehnes Y (2024)
Detection of doping substances in paired dried blood spots and urine samples collected during doping controls in Danish fitness centers
Drug Test Anal (in press)
DOI 10.1002/dta.3660, PubMed 38433478

Masuda S, Lemaitre F, Barten MJ, Bergan S, Shipkova M, van Gelder T, Vinks S, Wieland E, Bornemann-Kolatzki K, Brunet M, de Winter B, Dieterlen MT, Elens L, Ito T, Johnson-Davis K, Kunicki PK, Lawson R, Lloberas N, Marquet P, Millan O, Mizuno T, Moes DJAR, Noceti O, Oellerich M, Pattanaik S et al. (2024)
Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Ther Drug Monit (in press)
DOI 10.1097/FTD.0000000000001250, PubMed 39331837

Olsen T, Elshorbagy A, Stolt E, Åsberg A, Zaré HK, Bastani NE, Refsum H, Retterstøl K, Vinknes KJ (2024)
Acute effects of oral mesna administration on the full amino acid profile and 3-methylhistidine: secondary results from the CYLOB dose-finding study
Amino Acids, 56 (1), 39
DOI 10.1007/s00726-024-03398-2, PubMed 38844567

Pagnon de la Vega M, Syvänen S, Giedraitis V, Hooley M, Konstantinidis E, Meier SR, Rokka J, Eriksson J, Aguilar X, Spires-Jones TL, Lannfelt L, Nilsson LNG, Erlandsson A, Hultqvist G, Ingelsson M, Sehlin D (2024)
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
Acta Neuropathol Commun, 12 (1), 22
DOI 10.1186/s40478-024-01734-x, PubMed 38317196

Pivoriunas J, Vethe NT, Husebye E, Fagerland MW, Bergan S, Kristiansen O, Munkhaugen J, Sverre E (2024)
Validation of a novel direct method to determine reduced adherence to atorvastatin therapy
Eur Heart J Cardiovasc Pharmacother, 10 (4), 307-315
DOI 10.1093/ehjcvp/pvae001, PubMed 38196131

Ulvmoen A, Greiff V, Bechensteen AG, Inngjerdingen M (2024)
NKG2A discriminates natural killer cells with a suppressed phenotype in pediatric acute leukemia
J Leukoc Biol, 115 (2), 334-343
DOI 10.1093/jleuko/qiad112, PubMed 37738462

0.11s